In this section
@article{Parks:2018:cid/ciy401,
author = {Parks, T and Wilson, C and Curtis, N and Norrby-Teglund, A and Sriskandan, S},
doi = {cid/ciy401},
journal = {Clinical Infectious Diseases},
pages = {1434--1436},
title = {Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis.},
url = {http://dx.doi.org/10.1093/cid/ciy401},
volume = {67},
year = {2018}
}
TY - JOUR
AB - We evaluated the effect of adjunctive intravenous immunoglobulin (IVIG) on mortality in clindamycin-treated streptococcal toxic shock syndrome patients using a meta-analysis. In association with IVIG, mortality fell from 33.7% to 15.7% (risk ratio 0.46, 95% confidence intervals 0.26-0.83, p=0.010) with remarkable consistency across the single randomised and four non-randomised studies.
AU - Parks,T
AU - Wilson,C
AU - Curtis,N
AU - Norrby-Teglund,A
AU - Sriskandan,S
DO - cid/ciy401
EP - 1436
PY - 2018///
SN - 1058-4838
SP - 1434
TI - Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis.
T2 - Clinical Infectious Diseases
UR - http://dx.doi.org/10.1093/cid/ciy401
UR - https://academic.oup.com/cid/article/67/9/1434/4996609
UR - http://hdl.handle.net/10044/1/59344
VL - 67
ER -
